Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 870 across all filing types
Latest filing 2025-07-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Regulatory Filings Classification · 85% confidence The document is a standard HKEX prescribed form (FF301) titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts… on Movements in Securities.” It is a periodic compliance return to the Stock Exchange of Hong Kong under Chapter 19B listing rules, reporting share capital and treasury share balances for the month. It is neither a financial result release nor a capital raising announcement, but a routine regulatory submission. This best maps to the generic Regulatory Filings category (RNS).
2025-07-02 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is the full Articles of Association for TYK Medicines, Inc, detailing the company’s internal rules, share issuance, board structure, shareholder meeting procedures, financial and governance arrangements. This aligns with the Governance Information category (CGR) which covers reports detailing a company’s internal rules and governance practices, rather than an announcement or summary. It is not an AGM presentation, proxy statement or other regulatory notice but the actual constitution of the company.
2025-06-26 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 90% confidence The document provides a current list of the board of directors, their roles, and committee memberships for TYK Medicines. It is not an AGM presentation, earnings release, or regulatory report, but rather a board composition announcement. This aligns with Board/Management Information (MANG).
2025-06-26 English
POLL RESULTS OF THE 2024 ANNUAL GENERAL MEETING HELD ON JUNE 26, 2025&#x3b; AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is a formal announcement of the poll results from the 2024 Annual General Meeting, detailing vote counts on ordinary and special resolutions and the subsequent appointment of a non-executive director. It is not the actual AGM materials nor an annual report but rather the voting outcomes notification, which matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2025-06-26 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is an announcement of the poll results from the company’s Annual General Meeting held on 18 June 2025, listing each resolution and the votes for and against. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-06-18 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 92% confidence The document is titled “LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS” and provides the names of executive, non-executive, and independent non-executive directors along with their committee memberships. It is an announcement of the company’s board composition rather than a full report or meeting materials. This clearly matches the “Board/Management Information” category.
2025-06-13 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.